Muscle strength is associated with COVID-19 hospitalization in adults 50 years of age and older - Cheval, Boris; Sieber, Stefan; Maltagliati, Silvio; Millet, Grégoire P.; Formánek, Tomáš; Chalabaev, Aïna; Cullati, Stéphane; Boisgontier, Matthieu P. (medRxiv, 2021)
Background Weak muscle strength has been associated with a wide range of adverse health outcomes. Yet, whether individuals with weaker strength are more at risk for hospitalization due to severe COVID-19 is still unclear. The objective of this study was to investigate the independent association between muscle strength and COVID-19 hospitalization.Methods Data from 3600 adults 50 years of age and older were analyzed using logistic models adjusted for several chronic conditions, body mass index, age, and sex. Hand grip strength was repeatedly measured between 2004 and 2017 using a handheld dynamometer. COVID-19 hospitalization during the lockdown was self-reported in summer 2020 and was used an indicator of COVID-19 severity.Results Results showed that higher grip strength was associated with a lower risk of COVID-19 hospitalization (adjusted odds ratio [OR] per increase of 1 SD in grip strength = .64, 95% confidence interval [95% CI] = .45–.87, p = .015). Results also showed that age (OR for a 10-year period = 1.70, 95% CI = 1.32–2.20, p < .001) and obesity (OR = 2.01, 95% CI = 1.00– 3.69, p = .025) was associated with higher risk of COVID-19 hospitalization. Sensitivity analyses using different measures of grip strength as well as robustness analyses based on rare-events logistic regression and COVID-19 patients were consistent with the main results.Conclusion Muscle strength is an independent risk factor for COVID-19 severity in adults 50 years of age and older.Competing Interest StatementThe authors have declared no competing interest.Funding StatementB.C. is supported by an Ambizione grant (PZ00P1_180040) from the Swiss National Science Foundation (SNSF).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:SHARE was approved by the Ethics Committee of the University of Mannheim(waves 1-4) and the Ethics Council of the Max Plank Society(waves 4-7).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis SHARE dataset is available at http://www.share-project.org/data-access.html. http://www.share-project.org/data-access.html